Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consistency of Agrippal Vaccine Lots in Healthy Adults
NCT00617851Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of subunit inactivated influenza vaccine in influenza (4 arms), sponsored by Novartis. Primary endpoint: Geometric Mean Titers at 21 days. Started Nov 2007; status: completed.
02
Drugs
subunit inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00617851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617851.